B Toth1, W Würfel2, M K Bohlmann3, G Gillessen-Kaesbach4, F Nawroth5, N Rogenhofer6, C Tempfer7, T Wischmann8, M von Wolff9. 1. Abteilung für Gynäkologische Endokrinologie und Fertilitätsstörungen, Universitätsfrauenklinik Heidelberg, Heidelberg. 2. Kinderwunsch Centrum München-Pasing, München. 3. Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Mannheim, Mannheim. 4. Institut für Humangenetik, Universität zu Lübeck, Lübeck. 5. Facharzt-Zentrum für Kinderwunsch, Pränatale Medizin, Endokrinologie und Osteologie, Hamburg. 6. Hormon und Kinderwunschzentrum der Ludwig-Maximilians-Universität München, München. 7. Universitätsfrauenklinik der Ruhr-Universität Bochum, Marienhospital Herne, Herne. 8. Institut für Medizinische Psychologie im Zentrum für Psychosoziale Medizin des Universitätsklinikums Heidelberg, Heidelberg. 9. Inselspital, Universitätsfrauenklinik, Abteilung Gynäkologische Endokrinologie und Reproduktionsmedizin, Bern, Switzerland.
Abstract
Purpose: Official guideline coordinated and published by the German Society of Gynecology and Obstetrics (DGGG). Aim of the guideline was to standardize the diagnosis and treatment of patients with recurrent miscarriage (RM). Recommendations were proposed, based on the current national and international literature and the experience of the involved physicians. Consistent definitions, objective assessments and standardized therapy were applied. Methods: Members of the different involved societies developed a consensus in an informal process based on the current literature. The consensus was subsequently approved by the heads of the scientific societies. Recommendations: Recommendations for the diagnosis and treatment of patients with RM were compiled which took the importance of established risk factors such as chromosomal, anatomical, endocrine, hemostatic, psychological, infectious and immunological disorders into consideration.
Purpose: Official guideline coordinated and published by the German Society of Gynecology and Obstetrics (DGGG). Aim of the guideline was to standardize the diagnosis and treatment of patients with recurrent miscarriage (RM). Recommendations were proposed, based on the current national and international literature and the experience of the involved physicians. Consistent definitions, objective assessments and standardized therapy were applied. Methods: Members of the different involved societies developed a consensus in an informal process based on the current literature. The consensus was subsequently approved by the heads of the scientific societies. Recommendations: Recommendations for the diagnosis and treatment of patients with RM were compiled which took the importance of established risk factors such as chromosomal, anatomical, endocrine, hemostatic, psychological, infectious and immunological disorders into consideration.
Authors: Kristin Baumann; Petra Beuter-Winkler; Andreas Hackethal; Thomas Strowitzki; Bettina Toth; Michael K Bohlmann Journal: Am J Reprod Immunol Date: 2013-06-25 Impact factor: 3.886